Literature DB >> 12803586

A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units.

A Oldner1, P Rossi, S Karason, A Aneman.   

Abstract

BACKGROUND: This practice survey was performed to analyse the indications for use of vasopressor/inotropic drugs, preferred drugs and doses as well as concomitant monitoring and desired haemodynamic target values in Scandinavian ICUs. An internet-based reporting system was implemented.
METHODS: A total of 223 ICUs were identified in the Scandinavian countries and invited to participate in a one-day point-prevalence study. An internet-based database was constructed and a practice survey protocol designed to identify haemodynamic monitoring, indications for vasopressor/inotropic drug-therapy, fluids used for volume loading, pretreatment circulatory state, actual and targeted haemodynamic variables. Patients were eligible for the study if on vasopressor/inotropic drug-therapy for more than 4 h.
RESULTS: A total of 114 ICUs participated. A total of 114 adult patients matched the inclusion criteria. Sixty-seven per cent of the patients had received vasopressor/inotropic drug-treatment for >24 h and 32% received more than one drug. Arterial hypotension (92%) and oliguria (50%) were most common indications. Fluid loading prior to therapy was reported in 87% of patients. Dopamine (47%) and noradrenaline (44%) were the most commonly used drugs followed by dobutamine (24%). No other drug exceeded 6%. Non-catecholamine drugs were rarely used even in cardiac failure patients. Invasive arterial pressure was monitored in 95% of patients, pulmonary artery catheters were used in 19%. Other cardiac output monitoring techniques were used in 8.5% of the patients.
CONCLUSION: Dopamine and noradrenaline seem to be the most commonly used inotropic/vasopressor drugs in Scandinavia. Traditional indications for inotropic/vasopressor support as hypotension and oliguria seem to be most common. Invasive monitoring was used in almost all patients, whereas a limited use of pulmonary artery catheters was noted. The internet-based reporting system proved to be an efficient tool for data collection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803586     DOI: 10.1034/j.1399-6576.2003.00129.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

Review 1.  The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients.

Authors:  Ishaq Lat; Craig M Coopersmith; Daniel De Backer; Craig M Coopersmith
Journal:  Intensive Care Med Exp       Date:  2021-03-01

2.  The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.

Authors:  Ishaq Lat; Craig M Coopersmith; Daniel De Backer
Journal:  Crit Care Med       Date:  2021-04-01       Impact factor: 9.296

3.  Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.

Authors:  Xian-Bo Pei; Peng-Lin Ma; Jian-Guo Li; Zhao-Hui Du; Qing Zhou; Zhang-Hong Lu; Luo Yun; Bo Hu
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

4.  Practice of hemodynamic monitoring and management in German, Austrian, and Swiss intensive care units: the multicenter cross-sectional ICU-CardioMan Study.

Authors:  Sandra Funcke; Michael Sander; Matthias S Goepfert; Heinrich Groesdonk; Matthias Heringlake; Jan Hirsch; Stefan Kluge; Claus Krenn; Marco Maggiorini; Patrick Meybohm; Cornelie Salzwedel; Bernd Saugel; Gudrun Wagenpfeil; Stefan Wagenpfeil; Daniel A Reuter
Journal:  Ann Intensive Care       Date:  2016-05-31       Impact factor: 6.925

5.  Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort.

Authors:  Søren H Smith; Anders Perner
Journal:  Crit Care       Date:  2012-05-08       Impact factor: 9.097

6.  Fluid loading and norepinephrine infusion mask the left ventricular preload decrease induced by pleural effusion.

Authors:  Kristian Borup Wemmelund; Viktor Kromann Ringgård; Simon Tilma Vistisen; Janus Adler Hyldebrandt; Erik Sloth; Peter Juhl-Olsen
Journal:  Intensive Care Med Exp       Date:  2017-09-11

7.  Current use of vasopressors in septic shock.

Authors:  Thomas W L Scheeren; Jan Bakker; Daniel De Backer; Djillali Annane; Pierre Asfar; E Christiaan Boerma; Maurizio Cecconi; Arnaldo Dubin; Martin W Dünser; Jacques Duranteau; Anthony C Gordon; Olfa Hamzaoui; Glenn Hernández; Marc Leone; Bruno Levy; Claude Martin; Alexandre Mebazaa; Xavier Monnet; Andrea Morelli; Didier Payen; Rupert Pearse; Michael R Pinsky; Peter Radermacher; Daniel Reuter; Bernd Saugel; Yasser Sakr; Mervyn Singer; Pierre Squara; Antoine Vieillard-Baron; Philippe Vignon; Simon T Vistisen; Iwan C C van der Horst; Jean-Louis Vincent; Jean-Louis Teboul
Journal:  Ann Intensive Care       Date:  2019-01-30       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.